# Bortezomib

NDC: 63759-3032
Generic name: Bortezomib
Labeler / Manufacturer: Shilpa Medicare Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20240925

FDA application: NDA212782

## Active ingredients

- BORTEZOMIB: 3.5 mg/1.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63759-3032"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63759-3032
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61539d49-dc21-4576-8813-4bc8abf3868c